ZITRO 500 MG BT 3

They are based on the antibacterial activity and pharmacokinetic characteristics of azithromycin. They take into account both the clinical studies conducted with this medicine and its place in the range of antibacterial products currently available. They are limited to infections caused by bacteria defined as sensitive, including

DIABIPHAGE 1000 MG BT 60

Treatment of type 2 diabetes, especially in case of overweight, when diet and physical exercise are not enough to restore glycemic balance.

In adults :

DIABIPHAGE can be used as monotherapy or in combination with other oral antidiabetic agents or insulin.

In children over 10 years old and adolescents :

DIABIPHAGE 850 MG BT 60

Treatment of type 2 diabetes, especially in case of overweight, when diet and physical exercise are not enough to restore glycemic balance.

In adults :

DIABIPHAGE can be used as monotherapy or in combination with other oral antidiabetic agents or insulin.

In children over 10 years old and adolescents :

CIPRO 200 MG BT 1

Treatment of the following infections. Particular attention should be paid to information available on bacterial resistance to ciprofloxacin before initiating treatment. Official recommendations regarding the appropriate use of antibacterial should be taken into account.

In adults :

CIPRO 500 MG BT 14

Treatment of the following infections. Particular attention should be paid to information available on bacterial resistance to ciprofloxacin before initiating treatment. Official recommendations regarding the appropriate use of antibacterial should be taken into account.

In adults :

CIPRO 750 MG BT 14

Treatment of the following infections. Particular attention should be paid to information available on bacterial resistance to ciprofloxacin before initiating treatment. Official recommendations regarding the appropriate use of antibacterial should be taken into account.

In adults :